⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

GILD

Gilead Sciences, Inc.

Healthcare · Drug Manufacturers - General

156.04USD

-1.1500 (-0.73%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on GILD.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$2.21▲$2.252
Next quarter$2.12▼$2.2534
Current year-$0.43▲-$0.7761
Next year$9.97▲$9.6352

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30-$7.25-$6.75+0.50 (+6.9%)
2026-03-31$1.91$2.03+0.12 (+6.2%)
2025-12-31$1.81$1.86+0.05 (+2.8%)
2025-09-30$2.14$2.47+0.33 (+15.7%)

Wall Street coverage

437 ratings from 45 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
B of A SecuritiesMaintainedBuy$168 $172Oct 20, 2026
RBC CapitalMaintainedSector Perform$123 $126Oct 8, 2026
Cantor FitzgeraldReiteratedOverweight$155Oct 8, 2026
Truist SecuritiesMaintainedBuy$150 $158Oct 7, 2026
JP MorganMaintainedOverweight$160 $170Oct 7, 2026
Morgan StanleyMaintainedOverweight$165 $163Oct 7, 2026
HSBCMaintainedBuy$155 $175Sep 10, 2026
RBC CapitalMaintainedSector Perform$120 $123Aug 5, 2026
Cantor FitzgeraldReiteratedOverweight$155Aug 5, 2026
NeedhamReiteratedBuy$170Aug 5, 2026
BarclaysMaintainedEqual-Weight$155 $145Jul 29, 2026
Morgan StanleyMaintainedOverweight$166 $165Jul 27, 2026
Leerink PartnersDowngraded from OutperformMarket Perform$146 $127Jul 21, 2026
Morgan StanleyMaintainedOverweight$168 $166Jul 8, 2026
RBC CapitalMaintainedSector Perform$122 $120Jul 7, 2026
Truist SecuritiesMaintainedBuy$157 $156Jul 7, 2026
Cantor FitzgeraldReiteratedOverweight$155Jul 6, 2026
HSBCUpgraded from HoldBuy$133 $155Jul 6, 2026
Cantor FitzgeraldReiteratedOverweight$155Jun 16, 2026
Maxim GroupUpgraded from HoldBuy$165May 20, 2026
Truist SecuritiesReiteratedBuy$155 $157May 8, 2026
RBC CapitalMaintainedSector Perform$123 $122May 8, 2026
CitigroupMaintainedBuy$156 $165Apr 13, 2026
Morgan StanleyMaintainedOverweight$171 $175Apr 10, 2026
JefferiesInitiatedBuy$180Mar 10, 2026

Insider transactions

183 filings from 23 insiders · 23 buy / 17 sell over 6m

Officers and directors of GILD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Mercier JohannaOfficer, Chief Comm & Corp Aff OfficerSell3.0k$156.22$469kOct 15, 2026
Dickinson Andrew DOfficer, Chief Financial OfficerSell3.0k$156.22$469kOct 15, 2026
O'Day Daniel PatrickDirector; Officer, Chairman & CEOSell3.0k$148.63$446kOct 1, 2026
O'Day Daniel PatrickDirector; Officer, Chairman & CEOSell12.0k$147.72$1.77MOct 1, 2026
Burkhart ErinOfficer, SVP, ControllershipExercise2.2k——Sep 22, 2026
Burkhart ErinOfficer, SVP, ControllershipTax768$152.67$117kSep 22, 2026
Burkhart ErinOfficer, SVP, ControllershipExerciseRestricted Stock Unit2.2k——Sep 22, 2026
Dickinson Andrew DOfficer, Chief Financial OfficerSell3.0k$145.29$436kSep 15, 2026
Mercier JohannaOfficer, Chief Comm & Corp Aff OfficerSell1.6k$143.69$230kSep 15, 2026
Mercier JohannaOfficer, Chief Comm & Corp Aff OfficerSell800$144.46$116kSep 15, 2026
Mercier JohannaOfficer, Chief Comm & Corp Aff OfficerSell600$145.29$87kSep 15, 2026
Dickinson Andrew DOfficer, Chief Financial OfficerExercise2.8k——Sep 10, 2026
Dickinson Andrew DOfficer, Chief Financial OfficerTax1.3k$144.81$195kSep 10, 2026
Dickinson Andrew DOfficer, Chief Financial OfficerExerciseRestricted Stock Unit2.8k——Sep 10, 2026
O'Day Daniel PatrickDirector; Officer, Chairman & CEOExercise8.8k——Sep 10, 2026
O'Day Daniel PatrickDirector; Officer, Chairman & CEOTax4.2k$144.81$613kSep 10, 2026
O'Day Daniel PatrickDirector; Officer, Chairman & CEOExerciseRestricted Stock Unit8.8k——Sep 10, 2026
Berger DietmarOfficer, Chief Medical OfficerExercise533——Sep 10, 2026
Berger DietmarOfficer, Chief Medical OfficerTax263$144.81$38kSep 10, 2026
Berger DietmarOfficer, Chief Medical OfficerExerciseRestricted Stock Unit533——Sep 10, 2026

Analyst Notes

Sign in to write

No analyst notes on GILD yet.

Top voices on GILD

Members whose judged calls on GILD have played out most reliably.

No settled calls on GILD yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

26 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current616501Buy2.07
1 mo ago616501Buy2.07
2 mo ago616601Buy2.10
3 mo ago616700Buy2.03
Price target$160.19$126.00 – $185.00
+2.7% to target